# Clinical Study of the Safety of Menhycia® in 3-Month-Old Infants

> **NCT06389513** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **CanSino Biologics Inc.** · enrollment: 3011 (actual)

## Conditions studied

- Epidemic Meningitis

## Interventions

- **BIOLOGICAL:** MCV4

## Key facts

- **NCT ID:** NCT06389513
- **Lead sponsor:** CanSino Biologics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-06-12
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 3011 (ACTUAL)
- **Last updated:** 2025-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06389513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06389513, "Clinical Study of the Safety of Menhycia® in 3-Month-Old Infants". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06389513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*